Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials

Eliya Farah1, Matthew Kenney1, Anris Kica1

  • 1Life-Saving Therapies Network, 173 Heath Street, Ottawa, ON K1H 8L6, Canada.

PubMed

Insights

Active patient engagement in oncology clinical trial design improves outcomes and patient experiences. Prioritizing patient values is crucial for future cancer research, moving beyond simple participation.

Area of Science:

  • Oncology
  • Clinical Trials
  • Patient Engagement

Background:

  • Historically, oncology clinical trials relied on experts, with limited patient input in design.
  • Patient participation was key, but their active role in decision-making was restricted.

Purpose of the Study:

  • To review the literature on active patient engagement in oncology clinical trial design.
  • To assess the influence of patient involvement on clinical trial outcomes.

Main Methods:

  • Systematic literature search conducted in MEDLINE (Ovid) and EMBASE.
  • Included studies focused on patient engagement in cancer clinical research design.

Main Results:

  • Seven studies met eligibility criteria, highlighting benefits of active patient involvement.
  • Benefits included enhanced recruitment strategies and more patient-centered outcomes.
  • Patient involvement led to tangible developments (e.g., resources) and indirect impacts (e.g., adherence).

Conclusions:

  • Future oncology trials must prioritize patient values and perspectives.
  • Regulatory bodies should encourage patient centricity through guidelines.
  • Patient involvement in research should expand beyond participation to active design contributions.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
145
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K